Gerard Koppelman

Gerard Koppelman

Gerard Koppelman is a clinician-scientist whose goal is to improve early diagnosis and prevention of asthma, and to optimize treatment of asthma in childhood. As a pediatric pulmonologist, he focuses on children with severe chronic lung disease. He investigates inception, progression and remission of chronic lung disease. In his research, Koppelman develops diagnostic DNA tests for asthma and identifies early biomarkers of disease. Major accomplishments include the identification of novel genes for asthma, eczema and hay fever, as well as epigenetic signatures in childhood asthma. Koppelman studies the function of asthma genes in cell models, and develops patient-based models to better understand asthma inception in childhood. Among his recent interests in the application of biological therapies in severe childhood asthma, and the use of genomics to improve personalized treatment of asthma.

Koppelman has received several national and international awards and prizes, and authored approximately 400 manuscripts.

He collaborates closely with patients in his research, and initiated a mini medical school to inform the public on progress in research and patient care.